Vascular Stents Market is expected to rise at a CAGR of 6.35% by 2032, analyses DelveInsight

The global vascular stents market was valued at USD 11,232.93 million in 2024 and is projected to grow at a CAGR of 6.35% from 2025 to 2032, reaching USD 18,277.68 million by 2032. Market growth is primarily driven by the increasing prevalence of cardiovascular diseases and associated risk factors such as diabetes, hypertension, and obesity, which are fueling the demand for effective vascular interventions.

Rising awareness of cardiovascular health and the expansion of screening programs are enabling earlier diagnosis and treatment of arterial blockages, boosting the adoption of stenting procedures. In addition, the growing number of angioplasty procedures globally is directly propelling the demand for vascular stents, as they are essential for restoring blood flow.

Moreover, continuous product innovation and advancements by leading market players are improving patient outcomes and expanding the application of stents across broader patient groups. Collectively, these factors are expected to accelerate the growth of the vascular stents market over the forecast period.

DelveInsight's Vascular Stents Market Insights report provides the current and forecast market analysis, individual leading Vascular Stents companies' market shares, challenges, Vascular Stents market drivers, barriers, and trends, and key Vascular Stents companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Vascular Stents Market Report
The Vascular Stents market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Vascular Stents market during the forecast period.
Notable Vascular Stents companies such as Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and several others are currently operating in the Vascular Stents market.
In June 2024, Royal Philips, a global health technology leader, reported the first implant of its Duo Venous Stent System following FDA premarket approval (PMA). The device is designed to address symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency (CVI).
In January 2024, W. L. Gore & Associates, Inc. received FDA approval for its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft), further expanding treatment options for complex vascular conditions.
Also in January 2024, Reflow Medical, Inc., a company specializing in cardiovascular medical devices, obtained the CE Mark certification in the European Union for its Bare Temporary Spur Stent System. This device is intended for the treatment of de novo or restenotic lesions in the infrapopliteal arteries, and is used in conjunction with a drug-coated balloon (DCB) to improve drug uptake and therapeutic outcomes.

To read more about the latest highlights related to the Vascular Stents market, get a snapshot of the key highlights entailed in the Global Vascular Stents Market Report https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Vascular Stents Overview

Vascular stents are small, expandable mesh-like devices implanted into blood vessels to keep them open and ensure adequate blood flow. They are widely used in treating conditions such as coronary artery disease, peripheral artery disease, and other vascular blockages caused by plaque buildup or blood clots.

Stents come in different types, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable vascular scaffolds (BVS). Among these, DES are most commonly used because they gradually release drugs that reduce the risk of restenosis (re-narrowing of the vessel).

By providing structural support and preventing vessel collapse, vascular stents play a vital role in minimally invasive cardiovascular procedures such as angioplasty, significantly improving patient outcomes and reducing the need for repeat interventions.

Vascular Stents Market Insights

North America is projected to hold the largest share of the vascular stents market in 2024, maintaining its dominance due to several key factors. The region has a high prevalence of cardiovascular diseases, supported by a well-established healthcare infrastructure, the presence of major market players, and the rapid adoption of advanced technologies. In addition, increased healthcare spending and favorable reimbursement policies further strengthen its leading market position.

According to the Centers for Disease Control and Prevention (CDC, 2024), in 2022, around 4.9% of adults in the U.S. were diagnosed with coronary heart disease. By 2023, an estimated 12.1 million Americans were projected to have atrial fibrillation. Each year, more than 795,000 people in the U.S. suffer a stroke, of which about 610,000 are first-time cases, while nearly 185,000 strokes (one in four) occur in individuals with a prior history of stroke. The rising burden of obesity, hypertension, diabetes, and unhealthy lifestyle patterns has significantly increased the incidence of coronary artery disease and stroke, thereby driving the demand for interventional procedures such as coronary angioplasty. Since vascular stents are integral to restoring and maintaining blood flow in these procedures, their adoption continues to rise across the region.

Furthermore, awareness initiatives in the U.S. are contributing to early diagnosis, preventive care, and timely interventions, further supporting market growth. For example, American Heart Month (February 2024), led by the American Heart Association (AHA), highlighted cardiovascular health through activities such as Heart Walks, advocacy programs, and heart-healthy lifestyle campaigns, encouraging preventive measures and treatment uptake, including stenting procedures.

To know more about why North America is leading the market growth in the Vascular Stents market, get a snapshot of the Vascular Stents Market Outlook https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Vascular Stents Market Dynamics

According to the British Heart Foundation (2025), an estimated 640 million people worldwide are living with heart and circulatory diseases. Among them, coronary (ischemic) heart disease is the most prevalent, affecting around 200 million individuals globally-including 110 million men and 80 million women.

This high disease burden makes ischemic heart disease one of the primary factors driving the vascular stents market. Characterized by narrowing or blockage of the coronary arteries due to plaque buildup, the condition restricts blood flow to the heart, leading to angina, myocardial infarction, and other severe complications. Vascular stents-especially drug-eluting stents-are central to ischemic heart disease management, as they help restore and maintain arterial patency after angioplasty, making them a vital treatment option and fueling market growth.

Further supporting this trend, European Union (2024) data reported that in 2022, transluminal coronary angioplasties were performed most frequently (per 100,000 population) in Croatia (500.1), Germany (379.3), and Bulgaria (378.4). In other EU countries, the rate ranged from 156 to 342 per 100,000. As angioplasty remains a standard, minimally invasive procedure for treating narrowed or blocked vessels, the use of stents-particularly drug-eluting and bioresorbable types-has become indispensable for ensuring long-term vessel patency and reducing restenosis risk.

With the rising global cardiovascular disease burden and growing adoption of angioplasty procedures, the demand for vascular stents is expected to continue expanding significantly.

Vascular Stents Market Drivers:
Rising cases of cardiovascular disorders and associated risk factors
Increasing awareness and screening programs
Rising number of angioplasty procedures globally
Increase in product development activities

Get a sneak peek at the Vascular Stents market dynamics @ https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Scope of the Vascular Stents Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Vascular Stents Companies: Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.

Which MedTech key players in the Vascular Stents market are set to emerge as the trendsetter, explore @ Vascular Stents Companies https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.